Get in Touch

Setting the New
Standard

Omics That Scale With Precision

Why Scale Matters:

Reveal Hidden Proteomic and Multiomic Insights

Our high-content solutions in serum, spatial, and single-cell proteomics and multi-omics offer the highest levels of content, precision and unique scalability in the life science industry.

Status Quo Results

Conventional methods
miss critical insights

Unique Scale Reveals
Predictive Impact

Unique Scale Across Products

Across all of our proteomic and multiomic solutions, we deliver unmatched content, precision, and the leading scalability in the industry.

Unique Biomarkers With Early Predictive Insights

We deliver the leading proteomic and multiomic solutions that enable researchers to discover unique biological insights not accessible by other technologies.

Rapid Impact With the Precision That Customers Trust

We widen the aperture for deeper biological insights with best-in-class consistency and precision that our customers trust to make groundbreaking life science discoveries.
SomaScan

Plasma
Proteomics

CyTOF

Single-Cell
Proteomics

Hyperion

Spatial
Proteomics

Biomark

Genomics &
Multiomics

Setting the Standards for
Innovation in the Life Sciences

Standard BioTools: One company, leveraging 4 platforms that have pioneered cutting-edge proteomic and multi-omic research, setting the standard for innovation in content and precision at scale.

Customer Innovations to Pave the Way to Tomorrow

CyTOF

Single cell proteomics:
Every marker, all at once

Inventor of high multiplex single cell proteomics

2008

High dimensional CyTOF launched

2019

50 Simultaneous functional and surface markers

2024

First fully automated highplex panel + Software (MDIPA)

Hyperion

Spatial proteomics: The widest dynamic range, highest multiplex and throughput

The pioneer of spatial proteomics

2014

Introduction of IMC

2017

Detailed spatial mapping

2024

50 markers simultaneously with up to 100x the throughput

SomaScan

The only proteomics platform that scales with precision

The pioneer of high plex plasma proteomics

2008

Proteins
0 k

2018

Proteins
0 k

2024

Proteins
0 k

BioMark

Genomics assays:
Anytime, anywhere

The Pioneer of walk away genomics and multiomics

2008

First system capable of automating reactions at nanoliter scale for gene expression, genotyping, and digital PCR

2012

Introduction of automated single cell genomics

2024

The only walk-away automated benchtop qPCR and library prep system

4 leading high content platforms, to span biomarkers needed for customers

CyTOF

Single cell proteomics:
Every marker, all at once

Hyperion

Spatial proteomics: The widest dynamic range, highest multiplex and throughput

SomaScan

The only proteomics platform that scales with precision

BioMark

Genomics assays:
Anytime, anywhere

Leading the Field in Peer Reviewed Clinical Research

Our scalable platforms also have the deepest validation in clinical research studies that matter across 12,500+ Studies

Our proteomics platforms have led to breakthroughs in a wide reange of applications critical to human health, including immuno-oncology, cardiometabolic disease, neurology, autoimmune, and infectious disease. Additionally, our multiomic systems are creating leading impact beyond human health in agrigenomics and broader pathogen detection.

Platforms That Uniquely
Scale With Precision

Unique scale and innovation to match the needs of tomorrow

Widest Degree of Functional
Proteomics Simultaneously

Plasma Proteomics

Widest Coverage &
Highest Precision

3x

more proteins

<0.5x

CVS

Single-Cell Proteomics

Widest Coverage &
Highest Multiplex

5-10x

more functional
proteins

2x

more markers

Spatial Proteomics

Widest Dynamic Range & Highest Throughput

5-10x

more functional
proteins

35-100x

more throughput

Genomics

Fastest Speed to Insights & Least Hands-on Time

2x

speed to
insights

2x

less hands-on
time

Published Data With
High Application Impact

12,500+ Data Sets Prove High-Content Biomarkers Make a Difference

Categories

Categories
  • All
  • Biomark
  • CyTOF
  • Hyperion
  • SomaScan
SomaScan
Nature Medicine
Undulating changes in human plasma proteome profiles across the lifespan.
Biomark
Molecular Therapy (cell.com)
Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin.
Hyperion
Nature
The spatial landscape of lung pathology during COVID-19 progression.
CyTOF
Nature Cardiovascular Research
Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis.
Hyperion
Nature
Spatial predictors of immunotherapy response in triple-negative breast cancer.
Hyperion
Nature
Single-cell spatial landscapes of the lung tumour immune microenvironment.
Hyperion
Nature
Single-cell spatial immune landscapes of primary and metastatic brain tumours.
CyTOF
Aging and Disease
Single-Cell Atlas of Atherosclerosis Patients by Cytof: Circulatory and Local Immune Disorders.
Hyperion
Cell Rep
Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry.
SomaScan
Science Translational Medicine
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s disease.
SomaScan
Science Translational Medicine
Proteomic analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment.
SomaScan
JCO Precision Oncology
Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer.
SomaScan
Nature Scientific Reports
Plasma proteome of growing tumors | Scientific Reports.
SomaScan
Nature Medicine
Plasma protein patterns as comprehensive indicators of health.
SomaScan
Science
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.

Explore the Technology

Learn How Our Solutions
Uncover Hidden Proteomics 

SomaScan

Plasma
Proteomics

CyTOF

Single-Cell
Proteomics

Hyperion

Spatial
Proteomics

Biomark

Genomics &
Multiomics

Scroll to Top

Get $10 for every friend you refer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor.